Shares of Eden Research plc (LON:EDEN – Get Free Report) rose 2.8% during trading on Tuesday following insider buying activity. The company traded as high as GBX 4.18 ($0.05) and last traded at GBX 3.70 ($0.05). Approximately 12,234,783 shares were traded during trading, an increase of 664% from the average daily volume of 1,602,016 shares. The stock had previously closed at GBX 3.60 ($0.04).
Specifically, insider Alexander John Abrey bought 540,540 shares of the company’s stock in a transaction that occurred on Tuesday, January 28th. The shares were acquired at an average cost of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($26,902.58).
Eden Research Stock Performance
The stock has a market cap of £19.73 million, a price-to-earnings ratio of -200.00 and a beta of 0.92. The company’s 50-day simple moving average is GBX 3.88 and its 200-day simple moving average is GBX 4.01. The company has a quick ratio of 2.42, a current ratio of 3.80 and a debt-to-equity ratio of 1.25.
About Eden Research
Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.
Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.
Featured Stories
- Five stocks we like better than Eden Research
- Do ETFs Pay Dividends? What You Need to Know
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- What is the Euro STOXX 50 Index?
- What Does the Future Hold for Eli Lilly?
- 5 discounted opportunities for dividend growth investors
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Eden Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eden Research and related companies with MarketBeat.com's FREE daily email newsletter.